📧 The October NAoPri newsletter is available! With updates from our recent publications 👉 New-look October Quarterly Report 👉 NAoPri Patient Guide. Sign up 👉breastcanceraudits@rcseng.ac.uk buff.ly/lVZlDBX #BreastCancerAudit @natcan-news.bsky.social @collegeofsurgeons.bsky.social @hqip.bsky.social
Posts by Diana Withrow
We are recruiting!
Applications are open for three data scientists to join NATCAN.
⌛ Closing date: 26/09/2025
To find out more and to apply, visit our website👇
buff.ly/jt8Bz2v
NB: Applications submitted via LinkedIn will not be accepted.
Key takeaway: Although general health and environmental factors couldn't be ruled out, socioeconomic factors, certain demographic characteristics, and cancer diagnosis and registry practices may all play a significant role in driving such variation.
Really proud to see my latest publication out in print. A labour of love across many organisations and multidisciplinary collaborators to explore determinants of regional variation in incidence of non-malignant meningioma across the US. dx.doi.org/10.1002/cncr...
Come work with me @naopri-natcan.bsky.social and @naome-natcan.bsky.social on National Cancer Audits. 3 Data Scientist/Analyst positions available!
www.jobs.ac.uk/job/DOP019/d...
Dr. Anthony Fauci urges Americans not to accept "Normalization of Untruths".
Now with a link to the pdf rdcu.be/ebhmX
Interested in health, data, and ethnicity?
In the wake of COVID-19, HDR UK set up a Special Interest Group on Ethnicity Coding Standards and welcomed me and many many others to take part. It was a great example of open-collaboration that resulted in this paper in Nature Medicine.
We compared brain tumour incidence rates in Japan (lower) to those in Japanese Americans (lowest) and US NHW populations (highest). Conducted over 4 years and 3 continents, all a credit to the US NCI! onlinelibrary.wiley.com/doi/10.1002/...
In November, 2024, a Working Group of 22 scientists (including me!) met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus.
www.iarc.who.int/wp-content/u...